The stock opened higher at Sfr104, up 8.3% from the Sfr96 IPO offer price, valuing Medacta at Sfr2.08bn. The greenshoe of 855,000 shares was utilised, according to a statement from the SIX Swiss Exchange.
It closed at just above IPO price at Sfr96.10.Credit Suisse and Morgan Stanley were ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org